Cerebrospinal fluid neurofilament light levels mark grey matter volume in clinically isolated syndrome suggestive of multiple sclerosis
- PMID: 28537100
- DOI: 10.1177/1352458517711774
Cerebrospinal fluid neurofilament light levels mark grey matter volume in clinically isolated syndrome suggestive of multiple sclerosis
Erratum in
-
Corrigendum.Mult Scler. 2019 Feb;25(2):302. doi: 10.1177/1352458518819093. Epub 2018 Dec 3. Mult Scler. 2019. PMID: 30507278 No abstract available.
Abstract
Background: Brain atrophy is a known marker of irreversible tissue damage in multiple sclerosis (MS). Cerebrospinal fluid (CSF) osteopontin (OPN) and neurofilament light chain (NF-L) have been proposed as candidate surrogate markers of inflammatory and neurodegenerative processes in MS.
Objective: To evaluate the relationship between CSF NF-L and OPN levels and brain grey and white matter volumes in patients with clinically isolated syndrome (CIS) suggestive of MS.
Methods: A total of 41 CIS patients and 30 neurological controls (NCs) were included. CSF NF-L and OPN were measured by commercial ELISA. Measures of brain volume (normalized brain volume (NBV), normalized grey matter volume (NGV), peripheral grey matter volume (PGV), normalized white matter volume (WMV), and ventricular volume) were obtained by SIENAX. Corpus callosum index (CCI) was calculated. Brain volumes were categorized into 'high' and 'low' according to the median value.
Results: CSF NF-L and OPN levels were higher in CIS patients in comparison with NCs. CIS patients with 'low' TGV, PGV, and TBV showed higher CSF NF-L levels than CIS patients with 'high' brain volumes. TGV and PGV correlated inversely with NF-L levels, whereas CCI was inversely related to OPN levels. CSF NF-L was the only independent predictor of TGV and PGV.
Conclusion: CSF NF-L tracks mainly grey matter damage in patients with CIS suggestive of MS.
Keywords: Clinically isolated syndromes; brain volume; neurofilament; osteopontin.
Similar articles
-
The predictive value of CSF multiple assay in multiple sclerosis: A single center experience.Mult Scler Relat Disord. 2019 Oct;35:176-181. doi: 10.1016/j.msard.2019.07.030. Epub 2019 Jul 28. Mult Scler Relat Disord. 2019. PMID: 31394405
-
Cerebrospinal fluid neurofilament tracks fMRI correlates of attention at the first attack of multiple sclerosis.Mult Scler. 2015 Apr;21(4):396-401. doi: 10.1177/1352458514546789. Epub 2014 Aug 28. Mult Scler. 2015. PMID: 25168208
-
Neurofilament light chain and oligoclonal bands are prognostic biomarkers in radiologically isolated syndrome.Brain. 2018 Apr 1;141(4):1085-1093. doi: 10.1093/brain/awy021. Brain. 2018. PMID: 29452342
-
Osteopontin (OPN) as a CSF and blood biomarker for multiple sclerosis: A systematic review and meta-analysis.PLoS One. 2018 Jan 18;13(1):e0190252. doi: 10.1371/journal.pone.0190252. eCollection 2018. PLoS One. 2018. PMID: 29346446 Free PMC article. Review.
-
The Cerebrospinal Fluid in Multiple Sclerosis.Front Immunol. 2019 Apr 12;10:726. doi: 10.3389/fimmu.2019.00726. eCollection 2019. Front Immunol. 2019. PMID: 31031747 Free PMC article. Review.
Cited by
-
Neurofilament Light Chain in Adult and Pediatric Multiple Sclerosis: A Promising Biomarker to Better Characterize Disease Activity and Personalize MS Treatment.Neurol Ther. 2023 Dec;12(6):1867-1881. doi: 10.1007/s40120-023-00535-z. Epub 2023 Sep 8. Neurol Ther. 2023. PMID: 37682513 Free PMC article. Review.
-
Biomarkers in autoimmune diseases of the central nervous system.Front Immunol. 2023 Apr 5;14:1111719. doi: 10.3389/fimmu.2023.1111719. eCollection 2023. Front Immunol. 2023. PMID: 37090723 Free PMC article. Review.
-
Demographic and disease-related factors impact on cerebrospinal fluid neurofilament light chain levels in multiple sclerosis.Brain Behav. 2023 Jan;13(1):e2873. doi: 10.1002/brb3.2873. Epub 2022 Dec 27. Brain Behav. 2023. PMID: 36573731 Free PMC article.
-
ISGylation is induced in neurons by demyelination driving ISG15-dependent microglial activation.J Neuroinflammation. 2022 Oct 20;19(1):258. doi: 10.1186/s12974-022-02618-4. J Neuroinflammation. 2022. PMID: 36261842 Free PMC article.
-
Serum-Based Biomarkers in Neurodegeneration and Multiple Sclerosis.Biomedicines. 2022 May 6;10(5):1077. doi: 10.3390/biomedicines10051077. Biomedicines. 2022. PMID: 35625814 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
